Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1649 1675
This examiner grants 54% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 16755198 | A Cell-Based Seeding Assay for Huntingtin Aggregation | Final Rejection | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17711099 | ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF | Non-Final OA | Eli Lilly and Company |
| 17211163 | COMBINATION THERAPY | Non-Final OA | Eli Lilly and Company |
| 17499777 | METHODS FOR DETECTING TRAUMATIC BRAIN INJURY | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY |
| 17568619 | BK CHANNEL-MODULATING PEPTIDES AND THEIR USE | Non-Final OA | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM |
| 17050775 | NATURAL KILLER CELLS ENGINEERED TO EXPRESS CHIMERIC ANTIGEN RECEPTORS WITH IMMUNE CHECKPOINT BLOCKADE | Final Rejection | Board of Regents, The University of Texas System |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy